EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Narang, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Narang, H. K.
Experimental Biology and Medicine 226:629-639 (2001)
© 2001 Society for Experimental Biology and Medicine


MINIREVIEW

A Critical Review of Atypical Cerebellum-Type Creutzfeldt-Jakob Disease: Its Relationship to ``New Variant'' CJD and Bovine Spongiform Encephalopathy

Harash K. Narang,1

Ken Bell International, Newcastle-upon-Tyne NE2 3DH,United Kingdom

Shortly after the appearance of bovine spongiform encephalopathy (BSE), Creutzfeldt-Jakob disease (CJD) was identified in young patients with nonclassical presentation such as difficulty in balancing and ataxia. The classical CJD in older patients starts with dementia. To distinguish between the two types, CJD in young persons has been termed ``new variant'' (nvCJD). The distinguishing features of classical CJD include initial presentation with dementia, confluent spongiform changes are very unusual in the cerebellum, and PrP plaques are rarely observed. For nvCJD, initially, difficulty with balancing and ataxia occurs, confluent spongiform changes are seen in the cerebellum, and a large number of PrP plaques are seen. The Icelandic observation of sheep scrapie revealed a predominantly ataxic form of scrapie, termed Type II, rather than the itchy form termed Type I. Both types have been known to exist in Europe. Since the clinical signs of Type II scrapie in sheep with trembling and ataxia are similar to those seen in BSE and nvCJD, this suggests that Type II is the cause of BSE and nvCJD. Over 8 years, from 1989 to 1996, I examined the clinical histories of 33 CJD cases aged between the ages of 18 and 84. Six under the age of 40 and 15 over the age of 40 had leading clinical features such as difficulty in balancing and ataxia similar to those seen in the young cases classified as ``nvCJD.'' Brains were examined from the six of 15 cases over the age of 40, which revealed similar pathology to that seen in young patients classified as ``nvCJD.'' These findings suggest that all age groups are susceptible to the strain of the agent derived from BSE cattle.

Key Words: bovine spongiform encephalopathy • Creutzfeldt-Jakob disease • nemavirus • protease-resistant protein (PrP) • scrapie • scrapie-associated fibril • spongiform encephalopathy




This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
H. Narang
A Critical Review of the Nature of the Spongiform Encephalopathy Agent: Protein Theory Versus Virus Theory
Experimental Biology and Medicine, January 1, 2002; 227(1): 4 - 19.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
H. K. Narang
Lingering Doubts about Spongiform Encephalopathy and Creutzfeldt-Jakob Disease
Experimental Biology and Medicine, July 1, 2001; 226(7): 640 - 652.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Experimental Biology and Medicine.